Cediranib effect on metastatic alveolar soft part sarcoma - - GEO DataSets - NCBI

Warning: The NCBI web site requires JavaScript to function. more...

Result Filters

Summary

Format

Summary
Summary (text)
Unique Identifier List

Send to:

Choose Destination

File
Clipboard
Collections

Links from GEO Profiles

Full record GDS4833

Cediranib effect on metastatic alveolar soft part sarcoma

Analysis of metastatic alveolar soft part sarcoma (ASPS) biopsies from patients treated with cediranib, a small-molecule inhibitor of vascular endothelial growth factor receptors. Results provide insight into molecular mechanisms underlying the substantial single-agent activity of cediranib on ASPS.

Organism:: Homo sapiens

Type:: Expression profiling by array, transformed count, 2 agent, 6 individual sets

Platform:: GPL570
Series:: GSE32569
12 Samples

Download data: CEL

DataSet

Accession:: GDS4833

ID:: 4833

PubMed Full text in PMC Similar studies GEO Profiles Analyze DataSet

Supplemental Content

Related information

PubMed
Related PubMed entries
Full text in PMC
PMC links
Similar studies
Similar studies
GEO Profiles
Related GEO
BioProject
BioProject links
GEO DataSets
Related GEO DataSets
Taxonomy
Taxonomy

Important Links

Recent activity

Clear Turn Off Turn On

Related DataSets for GEO Profiles (Select 104960000) (1)
GEO DataSets
Cediranib effect on metastatic alveolar soft part sarcoma
Cediranib effect on metastatic alveolar soft part sarcoma
Accession: GDS4833

GEO DataSets

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

You are here: NCBI > Genes & Expression > Gene Expression Omnibus (GEO) Datasets